The Management of Pregnancy and Delivery in 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency

被引:3
|
作者
Pipitone, Angela [1 ]
Raval, Donna B. [2 ]
Duis, Jessica [1 ]
Vernon, Hilary [1 ]
Martin, Regina [1 ]
Hamosh, Ada [1 ]
Valle, David [1 ]
Gunay-Aygun, Meral [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA
[2] NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA
关键词
3-hydroxy-3-methylglutaric CoA lyase deficiency; HMG-CoA lyase deficiency; pregnancy; SERIES;
D O I
10.1002/ajmg.a.37620
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
3-hydroxy-3-methylglutaric (HMG)-CoA lyase is required for ketogenesis and leucine degradation. Patients with HMG-CoA lyase deficiency typically present with hypoketotic hypoglycemia and metabolic acidosis, which can be fatal if untreated. The patient is a 28-year-old female with HMG-CoA lyase deficiency who presented at 4 weeks gestation for prenatal care. Protein intake as well as carnitine supplementation were gradually increased to support maternal and fetal demands up to 65 g per day for protein and 80 mg/kg/day for carnitine. Fetal growth was appropriate. At 36 5/7 weeks, she presented with spontaneous rupture of membranes. Twice maintenance 10% glucose-containing intravenous fluids were initiated. During labor, vomiting and metabolic acidosis developed. Delivery was by cesarean. Preeclampsia developed postpartum. The patient recovered well and was discharged home on postpartum day 5. Stress of pregnancy and labor and delivery can lead to metabolic decompensation in HMG-CoA lyase deficiency. Patients should be monitored closely by a biochemical geneticist, dietitian, and high-risk obstetrician at a tertiary care center during their pregnancy. Fasting should be avoided. Intravenous 10% glucose-containing fluids should be provided to prevent catabolism and metabolic decompensation during labor and delivery. (C) 2016 Wiley Periodicals, Inc.
引用
收藏
页码:1600 / 1602
页数:3
相关论文
共 50 条
  • [31] MEASUREMENT OF 3-HYDROXY-3-METHYLGLUTARYL-COA LYASE ACTIVITY IN AMNIOTIC CELLS AND IN CHORIONIC VILLI
    BARASH, V
    ELPELEG, O
    SHEFFER, R
    MANDEL, H
    WANDERS, RJA
    PRENATAL DIAGNOSIS, 1988, 8 (09) : 691 - 691
  • [32] Investigation of the oligomeric status of the peroxisomal isoform of human 3-hydroxy-3-methylglutaryl-CoA lyase
    Tuinstra, RL
    Burgner, JW
    Miziorko, HM
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 408 (02) : 286 - 294
  • [33] 3-METHYL-3-BUTENOIC ACID - AN ARTIFACT IN THE URINARY METABOLIC PATTERN OF PATIENTS WITH 3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY
    JAKOBS, C
    BOJASCH, M
    DURAN, M
    KETTING, D
    WADMAN, SK
    LEUPOLD, D
    CLINICA CHIMICA ACTA, 1980, 106 (01) : 85 - 89
  • [34] Disturbance of redox homeostasis as a contributing underlying pathomechanism of brain and liver alterations in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency
    Leipnitz, Guilhian
    Vargas, Carmen Regla
    Wajner, Moacir
    JOURNAL OF INHERITED METABOLIC DISEASE, 2015, 38 (06) : 1021 - 1028
  • [35] EVIDENCE THAT THE METABOLITES ACCUMULATING IN 3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY INDUCE OXIDATIVE STRESS IN RAT STRIATUM IN VIVO
    Fernandes, C. G.
    da Rosa, M. S.
    Seminotti, B.
    Leipnitz, G.
    Wajner, M.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S62 - S62
  • [36] 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE MEDIATES THE PREPARATION OF ITS SUBSTRATE DIASTEREOMERS AND IS INHIBITED BY (3R)-3-HYDROXY-3-METHYLGLUTARYL-COA
    HUPPERICH, M
    THOMER, A
    EGGERER, H
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1992, 373 (09): : 925 - 930
  • [37] CHOLESTEROL REGULATION OF 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE
    SHAPIRO, DJ
    RODWELL, VW
    FEDERATION PROCEEDINGS, 1971, 30 (03) : 1229 - &
  • [38] CT FINDINGS IN A CASE OF DEFICIENCY OF 3-HYDROXY-3-METHYLGLUTARYL-COA-LYASE
    LISSON, G
    LEUPOLD, D
    BECHINGER, D
    WALLESCH, C
    NEURORADIOLOGY, 1981, 22 (02) : 99 - 101
  • [39] 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE OF RAT INTESTINE
    LOUW, AI
    MOSBACH, EH
    FEDERATION PROCEEDINGS, 1971, 30 (02) : A347 - &
  • [40] Are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors renoprotective?
    Campese, VM
    Nadim, MK
    Epstein, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 : S11 - S17